Anti-TRP1/TYRP1 Antibody (Flanvotumab)
Catalog No.
F1467
Anti-TRP1/TYRP1 Antibody (Flanvotumab)
Featured Products
Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody targeting tyrosinase-related protein 1 (TYRP1), which is specifically expressed in melanocytes and melanoma cells. Flanvotumab functions through natural killer-mediated, antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has strong anti-tumor activity and good tolerability.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1188277-05-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IMC-20D7S, TA99, 20D7
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P48995
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TRP1 / TYRP1
Please avoid freeze-thaw cycles.